We are happy to welcome in our cluster axiom insights, a spin-off of the Deutsches Elektronen-Synchrotron (DESY) in Hamburg (Germany), that offers a highly sensitive imaging technology without depth restriction.
A sophisticated and patented method based on X-ray Fluorescence Imaging (XFI) is opening up completely new possibilities: a) It allows to reduce significantly the development costs and time spent on research b) axiom's new measurement method enables to assess the investment risk of a new product significantly better throughout the entire development phase. c) axiom's XFI method increases the probability of pharmaceutical products being approved substantially faster by Regulatory Authorities. The approach provides direct support of preclinical research processes. It allows to directly track your medical drug molecules, drug carriers or immune cells over time in vivo and without any depth limitations. This also allows obtaining new data at different points in time on the population dynamics of the tracked immune cells and visualize this information directly. This enables to quickly check the efficacy and safety of pipeline products at all stages of the development process. axiom's analyses can also be used to examine interesting product candidates independently of available data in case of an acquisition or licensing. XFI from axiom is a unique combination of technical imaging opportunities for your research. It allows to gain access to data at an extended depth as well as to new data that were previously not accessible due to the limitations of other modalities.
We are looking forward to see your active participation in the network!
You can find here more information about axiom insights.